Financial Gravity Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Financial Gravity Asset Management's BMY Position: Q4 2025 in Review
Financial Gravity Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 221 shares — an estimated $9.98K sold.
Financial Gravity Asset Management first reported a position in BMY in Q1 2018 and held it in 14 quarters. The position peaked at $75K in Q4 2019. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Financial Gravity Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Financial Gravity Asset Management sold 221 Bristol-Myers Squibb shares in Q4 2025, an estimated $9.98K.
- Financial Gravity Asset Management first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 14 quarters.
- Financial Gravity Asset Management's Bristol-Myers Squibb position peaked at $75K in Q4 2019.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Financial Gravity Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.